A Phase 2 Study of E6005 in Patients With Atopic Dermatitis

NCT01461941 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: E6005
DRUG: E6005 ointment (vehicle)

Sponsor

Organon and Co